A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann ...

New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...

It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive locally ...

Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer ... bevacizumab (bev) in treatment naïve patients with ...

Now, eight years later, Chris credits the treatment with saving his life, calling it nothing short of miraculous. Another ...

Stock analysts at Cantor Fitzgerald began coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) in a research note issued on Tuesday, Marketbeat.com reports. The brokerage set ...

Russia has claimed that they have innovated a cancer vaccine and they will distribute it for free. However, they haven't been ...

Dr Mayowa Kolade, a consultant nuclear medicine specialist at the University College Hospital, Ibadan, in this interview with ...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the first patient ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.